Navigation Links
Migraine Treatment Centers of America Welcomes Chronic Migraine Specialist in Phoenix, AZ

Phoenix, AZ (PRWEB) March 02, 2013

Migraine Treatment Centers of America (“Migraine Centers”) is pleased to welcome Abram Burgher, M.D. in the Phoenix, Arizona area. This new and exciting partnership will offer the Omega migraine procedure at Freedom Pain Hospital, the nation's first pain hospital.

Utilizing technology that is similar to a pacemaker, the Omega migraine procedure is used to treat chronic migraine pain through the implantation of a small device. The device confuses the nerves associated with chronic migraine pain, which prevents the pain signal from reaching the brain.

The Omega procedure is covered by most insurance providers for qualified patients, has seen a 90% success rate in targeted migraine conditions, and is designed to provide long-lasting pain relief. Prior to permanent implantation, each patient will undergo a trial, in which they will be able to determine whether the device offers sufficient pain relief and improved function.

The Omega procedure is offering hope, pain relief, and improved function to those who suffer from this debilitating, painful condition. Cynthia B., a migraine sufferer who has undergone the Omega procedure, says, “My professional and personal life has improved dramatically. I have not had to miss one day of work because of migraines. I’ve also been able to get off of all preventative medications.”

Dr. Burgher is a Phoenix-based, double board-certified pain management expert who completed his internship, residency, and fellowship in Pain Management at the world-renowned Mayo Clinic in Rochester, MN.

Dr. Burgher treats patients with chronic pain from conditions including migraines, chronic headaches and trigeminal neuralgia, with the help of the surgical facilities at Freedom Pain Hospital in Scottsdale, Arizona. This acute care and outpatient surgical facility is dedicated to a multi-disciplinary, complementary approach in the evaluation, diagnosis, and treatment of chronic pain.

In addition to his clinical practice, Dr. Burgher is dedicated to research, and works diligently toward furthering to technology development in the area of pain management. He is currently involved in clinical research in patient care and safety for individuals suffering with chronic pain. He is a clinical investigator and the Director of Investigator Relations at the HOPE Research Institute, and Vice President for Clinical Innovations at Pain Care Solutions. Dr. Burgher's main area of interest is on the applications for implanted pain therapy devices that can help manage chronic nerve pain.

Dr. Burgher is the lead author of various publications in peer-reviewed medical journals, as well as co-lead researcher in a human clinical trial supported by the National Institutes of Health.

“Dr. Abram Burgher’s pain management expertise and interest in advanced solutions for treatment make him an excellent partner for Migraine Treatment Centers of America in Phoenix,” said Alex Noffsinger, president of Migraine Centers.

About Migraine Treatment Centers of America

Migraine Treatment Centers of America (“Migraine Centers”) is committed to helping chronic migraine sufferers by providing access to educational tools, a network of leading physicians board-certified in interventional pain management, and evidence-based medical procedures to treat chronic migraine pain.

Migraine Centers is recognized for its Omega™ migraine procedure, a drug-free and long-lasting solution for chronic migraine pain. Its approach, based on a technique used for over 40 years, has been featured in numerous medical publications.

To learn more about Migraine Treatment Centers of America, visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Ice Cream Headaches Might Offer Clues to Migraines
2. Botox Offers Little Relief for Migraine, Study Finds
3. Migraines More Likely for People With Celiac Disease, Study Says
4. Two-Drug Combo Helps Teens With Migraines
5. Few Migraine Sufferers Referred for Behavioral Treatments
6. Red Wine, Weather May Trigger Migraines
7. Relief for Migraine Sufferers as The Life House Offers New Findings, Free Consults
8. Published clinical trial demonstrates efficacy of Sea-Band for migraine-related nausea
9. Good news: Migraines hurt your head but not your brain
10. Migraines Not Linked to Decline in Thinking Skills
11. Behavior issues are a bigger headache for children with migraines
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... The workstation boundaries for ... IMAGE Information Systems launches MED-TAB™ -- the world’s first portable DICOM-calibrated medical image ... 29 to December 4, 2015. , MED-TAB is expected to change teleradiology ...
(Date:12/1/2015)... ... , ... The importance of volumetric breast density assessment for ... abstracts accepted for presentation here, at the 101st Annual Radiology Society of North ... of Volpara Solutions’ quantitative breast imaging software tools for providing breast imaging and ...
(Date:12/1/2015)... ... December 01, 2015 , ... For ... That is why Hollister Incorporated has launched the VaPro Plus Pocket™ touch free ... in the VaPro touch free catheter portfolio,” said Michael Gresavage, Vice President North ...
(Date:12/1/2015)... ... December 01, 2015 , ... SAN FRANCISCO, Calif. (December 1, ... organization has awarded Education and Developmental Therapies (EDT), an Applied Behavior Analysis (ABA) ... exceptional special needs providers that excel in synthesizing the areas of clinical quality, ...
(Date:12/1/2015)... ... December 01, 2015 , ... McLean, ... been awarded a fixed price per sprint agile development contract to support the ... million over five years, provides software engineering, infrastructure, as well as operations and ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... During the recent 2015 Transcatheter Cardiovascular ... CA , Medinol Ltd. continued to introduce ... a satellite symposium, "The BioNIR eDES: The Role ... a renowned physician panel discussed the key attributes ... Stent System and the Medinol eDES Coronary Stent ...
(Date:12/1/2015)... YORK , Dec. 1, 2015 Relmada Therapeutics, ... the treatment of chronic pain, announced today that the company ... will be held December 1-3 at the Luxe Sunset Boulevard ... Sergio Traversa , CEO of Relmada Therapeutics, will present on ... Eastern Time). . Please register at least ...
(Date:12/1/2015)... Dec. 1, 2015  InCarda Therapeutics, Inc. (InCarda), a ... of therapies for cardiovascular conditions via the inhalation route, ... in Australia . InCarda is planning ... Australia in the first half of ... medical centers in Adelaide and ...
Breaking Medicine Technology: